ZLAB vs HCM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

ZLAB

55.1
AI Score
VS
ZLAB Wins

HCM

32.9
AI Score

Investment Advisor Scores

ZLAB

55score
Recommendation
HOLD

HCM

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZLAB HCM Winner
Revenue 52.17M 205.92M ZLAB
Net Income -19.89M -101.84M HCM
Net Margin -38.1% -49.5% HCM
Operating Income -36.05M -145.87M HCM
ROE -5.3% -16.8% HCM
ROA -3.7% -9.5% HCM
Total Assets 539.30M 1.07B ZLAB
Cash 91.69M 607.52M ZLAB
Current Ratio 3.45 2.13 HCM
Free Cash Flow -30.28M -77.82M HCM

Relative Price Performance (Last 90 Days)

ZLAB 1M: +0.8% · 3M: +33.4% HCM 1M: +22.3% · 3M: +27.4%

Current Technical Phase

ZLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.0% over 20 days), RSI 52

RSI (14): 51.7 · Price: $25.50

HCM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.0% over 20 days), RSI 63

RSI (14): 63.1 · Price: $14.57

Fundamentals Snapshot

Metric ZLAB HCM
Market Cap — —
Forward P/E -12.1 56.2
Trailing P/E — 146.3
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.0% 0.1%
Operating Margin -0.7% 0.0%
EPS -1.70 0.10
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZLAB is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.